Skip to main content

Primary Care Clinical Update 16 November 2023

1. Varicella (chickenpox) vaccination

The Joint Committee on Vaccination and Immunisation (JCVI) has recommended a vaccine against varicella (chickenpox) should be added to the UK’s routine childhood immunisation programme. The vaccine would be offered to all children in 2 doses, at 12 and 18 months of age. 

The JCVI has also recommended a temporary catch-up programme for older children be included in the initial rollout. Chickenpox cases were significantly reduced during the pandemic due to social restrictions, meaning there is currently a larger pool of children than usual without immunity. The catch-up programme would offer them protection against greater risks from the illness through later childhood or as adults, when chickenpox can be more severe.

Many other countries (such as Germany, Canada, Australia and the USA) already offer children chickenpox vaccination. The final decision about approving the proposed programme lies with the Secretary of State for Health and Social Care.

2. National vaccination and immunisation catch-up campaign for 2023/24

General practices are required to participate in a national vaccination and immunisation national catch-up campaign each year, as a requirement of the GP contracts. The 2023/24 national vaccinations and immunisations catch-up campaign will once focus on measles, mumps, and rubella (MMR). 

3. Covid-19 vaccination & flu vaccination

We are still encouraging patients to take up the offer of Covid-19 vaccination and flu vaccination if they are in an eligible group.

4. Covid-19 case numbers and hospitalisations

The most recent statistics suggest there has been a fall in Covid-19 cases and hospital admissions in the last few weeks, following an earlier increase from July to September 2023

5. Monitoring patients on hydroxychloroquine

Ensure we have an active monitoring system for patients on hydroxychloroquine.


Comments

Post a Comment

Popular posts from this blog

What is the difference between primordial prevention and primary prevention?

Primordial prevention and primary prevention are both crucial strategies for promoting health, but they operate at different levels. Primordial prevention aims to address the root causes of health problems and improve the wider determinants of health. It focuses on preventing the emergence of risk factors in the first place by tackling the underlying social, economic, and environmental determinants of health. This involves broad, population-wide interventions such as: Policies that promote healthy food choices: Think about initiatives like taxing sugary drinks to discourage unhealthy consumption, or providing subsidies for fruits and vegetables to make them more accessible. Urban planning that prioritises well-being: This could include creating walkable neighborhoods with safe cycling routes, ensuring access to green spaces for recreation and relaxation, and designing communities that foster social connections. Social programs that address inequality: Initiatives aimed at reducing pov...
Post a Comment
Read more

Talking to Patients About Weight-Loss Drugs

The use of weight-loss drugs such as GLP-1 receptor agonists (e.g., semaglutide, tirzepatide) has increased rapidly in recent years. These drugs can help some people achieve significant weight reduction, but they are not suitable for everyone and require careful counselling before starting treatment. By discussing benefits, risks, practicalities, and  uncertainties, clinicians can help patients make informed, realistic decisions about their treatment. Key points to discuss with patients 1. Indications and eligibility These drugs are usually licensed for adults with a specific BMI. They should be used alongside lifestyle interventions such as dietary change, increased physical activity, and behaviour modification. 2. Potential side effects – some can be serious Common adverse effects include nausea, vomiting, diarrhoea, and abdominal discomfort. Less common but more serious risks include gallstones, pancreatitis and visual problems. Patients should know what to watch for a...
Post a Comment
Read more

What makes a good doctor – and who gets to decide?

What Makes a Good Doctor? This is the question that Waseem Jerjes and I explore in the Journal of the Royal Society of Medicine . It is a key question that underpins the architecture of medical education, clinical practice, regulation, and professional identity. It cannot be answered by regulators, educators, or employers in isolation. It must be answered together – by doctors and patients – revisited throughout a career, and adapted as society and the profession change. Without that shared reflection, the danger is not simply disillusionment, but the erosion of the moral foundations of clinical work. As we enter an era when diagnosis will increasingly involve artificial intelligence and when performance metrics reward volume over value, reclaiming this question as a professional one is imperative. The integrity of our institutions – and of the practitioners within them – depends on reimagining excellence in inclusive, relational terms. A good doctor is not a flawless technician or a f...
1 comment
Read more